SPYGLASS PHARMA INC

Historical 13F Holders

Symbol
SGP
CUSIP
85220G109
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 85220G109 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D
24.1% 2/17/2026
Event 2/9/2026
New Enterprise Associates 17, L.P. 13D
22.2% 2/13/2026
Event 2/9/2026
Vensana Capital I GP, LLC 13D
9.9% 2/10/2026
Event 2/9/2026
Sands Capital Life Sciences Pulse Fund III (DE), L.P. 13G
7.8% 2/13/2026
Event 2/6/2026
Gilde Healthcare Holding B.V. 13D
6.6% 2/13/2026
Event 2/9/2026
Samsara BioCapital, L.P. 13G
6.3% 2/17/2026
Event 2/9/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 34.0 $884.00
2026 Q2 53 26.1 M $581 M
2026 Q1 35 25.4 M $655 M